![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761102
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411
https://www.prnewswire.com/news-releases/real-world-analysis-suggests-pediatric-inspired-regimens-lead-to-higher-overall-survival-in-adolescent-and-young-adult-patients-with-newly-diagnosed-acute-lymphoblastic-leukemia-301700806.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761102
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-presents-positive-interim-phase-23-results-of-rylaze-asparaginase-erwinia-chrysanthemi-recombinant-rywn-in-acute-lymphoblastic-leukemia-or-lymphoblastic-lymphoma-at-ash-2021-annual-meeting-301442693.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214609
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761102
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411
https://www.biospace.com/article/releases/erytech-announces-publication-of-its-phase-2b-trial-of-eryaspase-in-metastatic-pancreatic-cancer-in-the-european-journal-of-cancerfirst-asparaginase-based-therapy-to-demonstrate-clinical-efficacy-and-safety-in-solid-tumors/?s=62
https://www.reuters.com/article/us-iran-nuclear-drugs/u-s-sanctions-on-iran-threaten-access-to-certain-medicines-report-idUSKBN1X82IM?feedType=RSS&feedName=healthNews
http://www.pmlive.com/pharma_news/half_of_european_cancer_drug_trials_biased,_says_bmj_1302096
https://www.gov.uk/drug-safety-update/letters-and-drug-alerts-sent-to-healthcare-professionals-in-july-2019
https://www.fiercepharma.com/pharma/servier-armed-shire-cancer-drugs-builds-out-vision-for-u-s-future
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761102
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761102
https://www.fiercepharma.com/pharma-asia/big-pharma-s-cancer-drugs-take-50-plus-discount-for-china-s-insurance-scheme
http://www.pharmatimes.com/news/shire_completes_sale_of_oncology_franchise_to_servier_1250845
http://www.pmlive.com/pharma_news/immunology_keeps_shire_figures_solid_as_takeda_takeover_nears_1246459